Zevra Therapeutics Inc (ZVRA) USD0.0001
0.33%- This stock can be held in a
Create an alert
Stocks and Shares ISASell:$7.32
Buy:$7.33
Change:
$0.16
(2.20%)
$0.16
(2.20%)Market closed |
Prices delayed by at least 15 minutes
Sell:$7.32
Buy:$7.33
Change:$0.16
(2.20%)
$0.16
(2.20%)Market closed |
Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 12 September 2025 | Alvin ShihDirector | Buy Regular purchase transaction | 20,000 | $7.89 | $157,800.00 | 20,000 |
| 12 September 2025 | Tamara A FavoritoChairman of the Board | Buy Regular purchase transaction | 3,175 | $7.79 | $24,718.01 | 3,894 |
| 19 August 2025 | John B BodeIndependent Director | Buy Regular purchase transaction | 5,000 | $9.17 | $45,825.00 | 45,000 |
| 26 June 2025 | Rahsaan W. ThompsonChief Legal/Compliance Officer | Sell Regular sell transaction (market) | 24,000 | $9.21 | $221,004.00 | 42,666 |
| 28 March 2025 | Corey Michael WattonIndependent Director | Buy Regular purchase transaction | 300 | $7.84 | $2,351.52 | 1,800 |
| 19 March 2025 | John B BodeIndependent Director | Buy Regular purchase transaction | 10,000 | $7.96 | $79,624.00 | 40,000 |
| 14 February 2025 | Neil F McFarlanePresident/CEO | Sell Option/Award related | 30,544 | $8.05 | $245,961.67 | 191,516 |
| 13 February 2025 | Neil F McFarlanePresident/CEO | Sell Option/Award related | 61,273 | $7.86 | $481,428.09 | 222,060 |
| 13 February 2025 | R Laduane CliftonCFO | Sell Option/Award related | 11,000 | $7.86 | $86,471.00 | 51,361 |
| 13 February 2025 | Joshua M (Josh) SchaferChief Level Officer | Sell Option/Award related | 10,500 | $7.86 | $82,526.85 | 29,486 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 13 February 2025 | Neil F McFarlanePresident/CEO | Sell Option/Award related | 61,273 | $7.86 | $481,428.09 | 222,060 |
| 14 February 2025 | Neil F McFarlanePresident/CEO | Sell Option/Award related | 30,544 | $8.05 | $245,961.67 | 191,516 |
| 26 June 2025 | Rahsaan W. ThompsonChief Legal/Compliance Officer | Sell Regular sell transaction (market) | 24,000 | $9.21 | $221,004.00 | 42,666 |
| 12 September 2025 | Alvin ShihDirector | Buy Regular purchase transaction | 20,000 | $7.89 | $157,800.00 | 20,000 |
| 13 February 2025 | R Laduane CliftonCFO | Sell Option/Award related | 11,000 | $7.86 | $86,471.00 | 51,361 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.